IXICO plc (AIM:IXI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.75
0.00 (0.00%)
At close: Dec 5, 2025
IXICO Revenue
IXICO had revenue of 3.21M GBP in the half year ending March 31, 2025, with 0.16% growth. This brings the company's revenue in the last twelve months to 6.44M, up 7.27% year-over-year. In the fiscal year ending September 30, 2024, IXICO had annual revenue of 5.77M, down -13.49%.
Revenue (ttm)
6.44M
Revenue Growth
+7.27%
P/S Ratio
1.55
Revenue / Employee
79.46K
Employees
81
Market Cap
9.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 5.77M | -899.00K | -13.49% |
| Sep 30, 2023 | 6.67M | -1.98M | -22.89% |
| Sep 30, 2022 | 8.64M | -547.00K | -5.95% |
| Sep 30, 2021 | 9.19M | -342.00K | -3.59% |
| Sep 30, 2020 | 9.53M | 1.97M | 26.07% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
IXICO News
- 4 weeks ago - IXICO plc (PHYOF) Analyst/Investor Day - Slideshow - Seeking Alpha
- 5 months ago - FTSE Rises as Trump Calms Fed Fears, Wise Slumps - Investomania
- 1 year ago - IXICO PLC (FRA:PYPB) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 1 year ago - Full Year 2024 IXICO PLC Earnings Call Transcript - GuruFocus
- 1 year ago - Small Cap Stocks: Eco Buildings, IXICO, Electric Guitar - The Armchair Trader